Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review

Introduction Scientific progress and translation of evidence into practice is impeded by poorly described interventions. The Template for Intervention Description and Replication (TIDieR) was developed to specify the minimal intervention elements that should be reported.Objectives (1) To assess the...

Full description

Saved in:
Bibliographic Details
Main Authors: Marie Johnston, Claire Scott, Neil Scott, M De Bruin, Margaret Watson, Mícheál de Barra, Catriona Matheson, Christine Bond
Format: Article
Language:English
Published: BMJ Publishing Group 2019-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/12/e025511.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846143241966059520
author Marie Johnston
Claire Scott
Neil Scott
M De Bruin
Margaret Watson
Mícheál de Barra
Catriona Matheson
Christine Bond
author_facet Marie Johnston
Claire Scott
Neil Scott
M De Bruin
Margaret Watson
Mícheál de Barra
Catriona Matheson
Christine Bond
author_sort Marie Johnston
collection DOAJ
description Introduction Scientific progress and translation of evidence into practice is impeded by poorly described interventions. The Template for Intervention Description and Replication (TIDieR) was developed to specify the minimal intervention elements that should be reported.Objectives (1) To assess the extent to which outpatient pharmacy interventions were adequately reported. (2) To examine the dimension(s) across which reporting quality varies. (3) To examine trial characteristics that predict better reporting.Methods The sample comprised 86 randomised controlled trials identified in a Cochrane review of the effectiveness of pharmacist interventions on patient health outcomes. Duplicate, independent application of a modified 15-item TIDieR checklist was undertaken to assess the intervention reporting. The reporting/non-reporting of TIDieR items was analysed with principal component analysis to evaluate the dimensionality of reporting quality and regression analyses to assess predictors of reporting qualityResults In total, 422 (40%) TIDieR items were fully reported, 395 (38%) were partially reported and 231 (22%) were not reported. A further 242 items were deemed not applicable to the specific trials. Reporting quality loaded on one component which accounted for 26% of the variance in TIDieR scores. More recent trials reported a slightly greater number of TIDieR items (0.07 (95% CI 0.02 to 0.13) additional TIDieR items per year of publication). Trials reported an 0.09 (95% CI 0.04 to 0.14) additional TIDieR items per unit increase in impact factor (IF) of the journal in which the main report was published.Conclusions Most trials lacked adequate intervention reporting. This diminished the applied and scientific value of their research. The standard of intervention reporting is, however, gradually increasing and appears somewhat better in journals with higher IFs. The use of the TIDieR checklist to improve reporting could enhance the utility and replicability of trials, and reduce research waste.
format Article
id doaj-art-ea100b262a8c49bb9ac49bcd4c2ce12e
institution Kabale University
issn 2044-6055
language English
publishDate 2019-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-ea100b262a8c49bb9ac49bcd4c2ce12e2024-12-02T21:40:07ZengBMJ Publishing GroupBMJ Open2044-60552019-12-0191210.1136/bmjopen-2018-025511Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic reviewMarie Johnston0Claire Scott1Neil Scott2M De Bruin3Margaret Watson4Mícheál de Barra5Catriona Matheson6Christine Bond7Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UKThe Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UKThe Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UKRadboud University Medical Center, Radboud Institute for Health Sciences, Radboud, The NetherlandsThe Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UKLife Sciences, Brunel University London, Middlesex, UKUniversity of Stirling, Stirling, UKSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UKIntroduction Scientific progress and translation of evidence into practice is impeded by poorly described interventions. The Template for Intervention Description and Replication (TIDieR) was developed to specify the minimal intervention elements that should be reported.Objectives (1) To assess the extent to which outpatient pharmacy interventions were adequately reported. (2) To examine the dimension(s) across which reporting quality varies. (3) To examine trial characteristics that predict better reporting.Methods The sample comprised 86 randomised controlled trials identified in a Cochrane review of the effectiveness of pharmacist interventions on patient health outcomes. Duplicate, independent application of a modified 15-item TIDieR checklist was undertaken to assess the intervention reporting. The reporting/non-reporting of TIDieR items was analysed with principal component analysis to evaluate the dimensionality of reporting quality and regression analyses to assess predictors of reporting qualityResults In total, 422 (40%) TIDieR items were fully reported, 395 (38%) were partially reported and 231 (22%) were not reported. A further 242 items were deemed not applicable to the specific trials. Reporting quality loaded on one component which accounted for 26% of the variance in TIDieR scores. More recent trials reported a slightly greater number of TIDieR items (0.07 (95% CI 0.02 to 0.13) additional TIDieR items per year of publication). Trials reported an 0.09 (95% CI 0.04 to 0.14) additional TIDieR items per unit increase in impact factor (IF) of the journal in which the main report was published.Conclusions Most trials lacked adequate intervention reporting. This diminished the applied and scientific value of their research. The standard of intervention reporting is, however, gradually increasing and appears somewhat better in journals with higher IFs. The use of the TIDieR checklist to improve reporting could enhance the utility and replicability of trials, and reduce research waste.https://bmjopen.bmj.com/content/9/12/e025511.full
spellingShingle Marie Johnston
Claire Scott
Neil Scott
M De Bruin
Margaret Watson
Mícheál de Barra
Catriona Matheson
Christine Bond
Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review
BMJ Open
title Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review
title_full Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review
title_fullStr Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review
title_full_unstemmed Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review
title_short Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review
title_sort do pharmacy intervention reports adequately describe their interventions a template for intervention description and replication analysis of reports included in a systematic review
url https://bmjopen.bmj.com/content/9/12/e025511.full
work_keys_str_mv AT mariejohnston dopharmacyinterventionreportsadequatelydescribetheirinterventionsatemplateforinterventiondescriptionandreplicationanalysisofreportsincludedinasystematicreview
AT clairescott dopharmacyinterventionreportsadequatelydescribetheirinterventionsatemplateforinterventiondescriptionandreplicationanalysisofreportsincludedinasystematicreview
AT neilscott dopharmacyinterventionreportsadequatelydescribetheirinterventionsatemplateforinterventiondescriptionandreplicationanalysisofreportsincludedinasystematicreview
AT mdebruin dopharmacyinterventionreportsadequatelydescribetheirinterventionsatemplateforinterventiondescriptionandreplicationanalysisofreportsincludedinasystematicreview
AT margaretwatson dopharmacyinterventionreportsadequatelydescribetheirinterventionsatemplateforinterventiondescriptionandreplicationanalysisofreportsincludedinasystematicreview
AT michealdebarra dopharmacyinterventionreportsadequatelydescribetheirinterventionsatemplateforinterventiondescriptionandreplicationanalysisofreportsincludedinasystematicreview
AT catrionamatheson dopharmacyinterventionreportsadequatelydescribetheirinterventionsatemplateforinterventiondescriptionandreplicationanalysisofreportsincludedinasystematicreview
AT christinebond dopharmacyinterventionreportsadequatelydescribetheirinterventionsatemplateforinterventiondescriptionandreplicationanalysisofreportsincludedinasystematicreview